Genuv Inc. – Trademark Portfolio
Entity Type: 03
Genuv Inc. has 6 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 6 are successfully registered — a 100% registration rate. The portfolio includes marks such as GENUV and ATRIVIEW. Filings span 5 Nice Classification classes, with the highest activity in Class 42 (Computer & Scientific) and Class 10 (Medical Apparatus). This trademark owner is based in Seoul.
14 Cheonggyecheon-ro, Jung-gu
Seoul 04520 , KR
Showing of trademarks Trademarks
Trademark Classifications
Genuv Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Genuv Inc. have?
Genuv Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does Genuv Inc. file in?
Genuv Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 31 (Natural Agricultural Products), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Genuv Inc.'s most well-known trademarks?
Genuv Inc.'s registered trademark portfolio includes well-known marks such as GENUV and ATRIVIEW. These are among 6 currently registered trademarks in the portfolio.
What is Genuv Inc.'s trademark registration success rate?
Genuv Inc. has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.